하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
HIRONIC Co., Ltd. (CEO Jinwoo Lee), a leading medical aesthetic device manufacturer, announced the successful completion of its ‘V-RO Lifting (export name: New Doublo 2.0) Hands-on Seminar’ held recently in Busan, South Korea.
The seminar was designed to enhance the clinical proficiency of medical professionals in the southeastern region through comprehensive training programs featuring HIRONIC’s flagship HIFU (High-Intensity Focused Ultrasound) device, ‘V-RO Lifting (New Doublo 2.0)’, and Microneedle RF technology. Dr. Hyejung Cha of Areumdawoon Clinic led the seminar with both theoretical lectures and live demonstrations on combined treatments using HIFU, RF, and Microneedle RF technologies—receiving enthusiastic feedback from participants.
V-RO Lifting (New Doublo 2.0) is a next-generation lifting device that integrates HIFU and RF energies, offering precise targeting and a versatile range of cartridges to support various clinical applications.
“V-RO’s dual-energy system allows for enhanced lifting effects while improving pores, skin elasticity, and texture—all with a single device,” said Dr. Cha. “This seminar was valuable in sharing practical know-how that can be directly applied in real-world clinical settings.”
She further commented, “The newly released SYNERJET, based on micro-jet technology, also shows great promise for treating scars and pigmentation issues. It’s expected to significantly expand our clinical indications.”
A HIRONIC spokesperson stated, “V-RO offers precision energy control and a versatile configuration for combination treatments, making it an ideal solution for diverse clinical needs. We will continue to strengthen customer understanding and trust through region-specific seminars.”
